[Clinical application of serum 25OHD]

Area of Science:

• Endocrinology
• Geriatrics
• Nutritional Science

Background:

• Serum 25-hydroxyvitamin D (25OHD) is the standard biomarker for vitamin D status.
• Defining optimal 25OHD reference values for health outcomes remains a clinical challenge.
• Existing proposed thresholds (50 nmol/L for bone health, 75 nmol/L for parathyroid hormone) have significant implications for classifying vitamin D insufficiency, particularly in the elderly.

Purpose of the Study:

• To highlight the difficulties in establishing definitive reference values for serum 25OHD.
• To discuss the impact of different proposed reference values on vitamin D status classification in the elderly population.
• To emphasize the need for precise 25OHD measurements for clinical decision-making in osteoporosis management.

Main Methods:

• Review of current literature on vitamin D reference values.
• Analysis of the implications of proposed 25OHD thresholds (50 nmol/L and 75 nmol/L) on population classification.
• Discussion of the clinical relevance of accurate 25OHD measurements.

Main Results:

• Applying a 50 nmol/L threshold classifies nearly half of the elderly as vitamin D insufficient.
• Using a 75 nmol/L threshold classifies almost all elderly individuals as vitamin D insufficient.
• The choice of reference value significantly impacts the perceived prevalence of vitamin D insufficiency in older adults.

Conclusions:

• There is a critical need for precise and reliable serum 25OHD measurements.
• Accurate vitamin D assessment is essential for effective osteoporosis treatment.
• Standardized reference values and reimbursement policies are required for clinical utility and healthcare system integration.